372 related articles for article (PubMed ID: 20800088)
1. Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells.
Wallin H; Bjarnadottir M; Vogel LK; Wassélius J; Ekström U; Abrahamson M
Biochimie; 2010 Nov; 92(11):1625-34. PubMed ID: 20800088
[TBL] [Abstract][Full Text] [Related]
2. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.
Bjarnadottir M; Wulff BS; Sameni M; Sloane BF; Keppler D; Grubb A; Abrahamson M
Mol Pathol; 1998 Dec; 51(6):317-26. PubMed ID: 10193512
[TBL] [Abstract][Full Text] [Related]
3. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells.
Merz GS; Benedikz E; Schwenk V; Johansen TE; Vogel LK; Rushbrook JI; Wisniewski HM
J Cell Physiol; 1997 Dec; 173(3):423-32. PubMed ID: 9369956
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for amyloidosis related to hereditary brain hemorrhage.
Abrahamson M
Scand J Clin Lab Invest Suppl; 1996; 226():47-56. PubMed ID: 8981667
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
Vincents B; Onnerfjord P; Gruca M; Potempa J; Abrahamson M
Biol Chem; 2007 Apr; 388(4):437-46. PubMed ID: 17391065
[TBL] [Abstract][Full Text] [Related]
6. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C.
Gerhartz B; Ekiel I; Abrahamson M
Biochemistry; 1998 Dec; 37(49):17309-17. PubMed ID: 9860845
[TBL] [Abstract][Full Text] [Related]
7. Cystatin E1 and E2, new members of male reproductive tract subgroup within cystatin type 2 family.
Li Y; Friel PJ; McLean DJ; Griswold MD
Biol Reprod; 2003 Aug; 69(2):489-500. PubMed ID: 12700194
[TBL] [Abstract][Full Text] [Related]
8. Human cysteine proteinase inhibitors. Isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage.
Abrahamson M
Scand J Clin Lab Invest Suppl; 1988; 191():21-31. PubMed ID: 3073520
[TBL] [Abstract][Full Text] [Related]
9. Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients.
Gerhartz B; Abrahamson M
Biol Chem; 2002 Feb; 383(2):301-5. PubMed ID: 11934268
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteinase inhibitor in cultured human medullary thyroid carcinoma cells.
Barka T; van der Noen H; Patil S
Lab Invest; 1992 Jun; 66(6):691-700. PubMed ID: 1602739
[TBL] [Abstract][Full Text] [Related]
11. Towards novel anti-cancer strategies based on cystatin function.
Keppler D
Cancer Lett; 2006 Apr; 235(2):159-76. PubMed ID: 15893421
[TBL] [Abstract][Full Text] [Related]
12. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of differentially inhibited cysteine proteases by activity-based profiling using cystatin variants with tailored specificities.
Sainsbury F; Rhéaume AJ; Goulet MC; Vorster J; Michaud D
J Proteome Res; 2012 Dec; 11(12):5983-93. PubMed ID: 23082957
[TBL] [Abstract][Full Text] [Related]
14. Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: why is the L68Q variant amyloidogenic?
Rodziewicz-Motowidło S; Wahlbom M; Wang X; Lagiewka J; Janowski R; Jaskólski M; Grubb A; Grzonka Z
J Struct Biol; 2006 Apr; 154(1):68-78. PubMed ID: 16446102
[TBL] [Abstract][Full Text] [Related]
15. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M
J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039
[TBL] [Abstract][Full Text] [Related]
16. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
17. Association of human neuroglobin with cystatin C, a cysteine proteinase inhibitor.
Wakasugi K; Nakano T; Morishima I
Biochemistry; 2004 May; 43(18):5119-25. PubMed ID: 15122877
[TBL] [Abstract][Full Text] [Related]
18. Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye.
Barka T; van der Noen H
Anat Rec; 1994 Jul; 239(3):343-8. PubMed ID: 7943765
[TBL] [Abstract][Full Text] [Related]
19. Hinge-loop mutation can be used to control 3D domain swapping and amyloidogenesis of human cystatin C.
Orlikowska M; Jankowska E; Kołodziejczyk R; Jaskólski M; Szymańska A
J Struct Biol; 2011 Feb; 173(2):406-13. PubMed ID: 21074623
[TBL] [Abstract][Full Text] [Related]
20. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
